Dr. Prateek Bhatia is an accomplished clinician-scientist and Principal Investigator known for his exceptional contributions to pediatric hematology-oncology and molecular diagnostics. With 1,244 citations from 1,134 documents, 143 published documents, and an h-index of 20, he has established a significant global research footprint in childhood leukemia, germline variant profiling, novel anemia syndromes, and pharmacogenetic responses to therapy. His education and advanced clinical training in pathology, hematology, and health management have enabled him to integrate laboratory excellence with patient-centered research. As an Additional Professor at a premier national institute, he leads numerous competitive, high-impact funded projects supported by ICMR, SERB-DST, CSIR, DST, and international grant bodies. His work focuses on defining genetic subtypes, clonal evolution, actionable molecular targets, and developing next-generation sequencing platforms and rapid diagnostic solutions tailored for resource-constrained settings. His research interests span acute lymphoblastic leukemia genomics, bone marrow failure disorders, iron-related anemias, epigenomic alterations, and point-of-care device development. Recognized as a Fellow of prestigious academies, he continues to advance precision hematology through innovative, clinically meaningful discoveries. His overarching mission is to enhance diagnostic accuracy, refine risk stratification, and improve outcomes for children with complex blood disorders through science-driven, compassionate care.